Ryan Zimmerman Analyst PerformanceManaging Director at BTIG ResearchRyan Zimmerman is a stock analyst at BTIG Research focused in the medical sector, covering 33 publicly traded companies. Over the past year, Ryan Zimmerman has issued 97 stock ratings, including buy and hold recommendations. While full access to Ryan Zimmerman's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Ryan Zimmerman's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings147 Last 8 YearsBuy Recommendations88.81% 127 Buy RatingsCompanies Covered33 Unique Companies Ratings Distribution143RatingsDistribution of strong buy, buy, hold, and sell ratings by Ryan Zimmerman.RatingPercentageCount Strong Buy0.0%0 ratings Buy88.8%127 ratings Hold11.2%16 ratings Sell0.0%0 ratingsOut of 143 total stock ratings issued by Ryan Zimmerman at BTIG Research, the majority (88.8%) have been Buy recommendations, followed by 11.2% Hold.Best & Worst CallsBest Call0000.0%VCELAug 2017Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call000.0%ORGOAug 2021Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNASDAQ63.6% of companies on NASDAQ21 companiesNYSE33.3% of companies on NYSE11 companiesNYSEAMERICAN3.0% of companies on NYSEAMERICAN1 companyRyan Zimmerman, an analyst at BTIG Research, currently covers 33 companies listed on NASDAQ, NYSE and NYSEAMERICAN, with the majority traded on NASDAQ.Coverage FocusSector IconSectorPercentageMedical31 companies93.9%Miscellaneous1 company3.0%Manufacturing1 company3.0%Ryan Zimmerman of BTIG Research specializes in stock coverage within the Medical sector, with additional focus on and Manufacturing companies.Coverage IndustriesIndustryPercentageMED INSTRUMENTS18 companies54.5%MED PRODUCTS4 companies12.1%MEDICAL INFO SYS2 companies6.1%MED - BIOMED/GENE2 companies6.1%MED - DRUGS2 companies6.1%SURGICAL, MEDICAL, AND DENTAL INSTRUMENTS AND SUPPLIES2 companies6.1%Miscellaneous1 company3.0%MEDICAL SERVICES1 company3.0%MED/DENTAL - SUPP1 company3.0% About Ryan ZimmermanRyan Zimmerman is a Managing Director and Medical Technology Analyst at BTIG. He provides coverage across the medical technology sector, focusing primarily on orthopedic and surgical companies. Prior to BTIG, Mr. Zimmerman was a Senior Associate at Canaccord Genuity, providing medical technology coverage with an emphasis on musculoskeletal companies. Previously, he was the Director of Surgery at Advocate Christ Medical Center, where he oversaw operations for a Level 1 Trauma hospital in the Chicago area. Mr. Zimmerman also held hospital management roles at Presence Health, and was a Fellow in Hospital Management at the University of Pennsylvania Health System. He is board certified in hospital management, and is a Fellow in the American College of Healthcare Executives. Mr. Zimmerman earned a BS in anthropology and zoology from the University of Michigan, and a Masters of Healthcare Administration from the University of Illinois-Chicago School of Public Health.Follow on LinkedIn Ryan Zimmerman's Ratings History at BTIG Research Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter Export CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsMDTMedtronic6/3/2026Set Price Target$78.09$90.00Buy$0.0000.00% ROIMDTMedtronic6/3/2026Upgrade$78.09$90.00Buy$0.0000.00% ROIMOBIMobia Medical6/2/2026Initiated Coverage$13.50$19.00Buy$0.0000.00% ROIMDAISpectral AI5/26/2026Boost Price Target$2.42$4.00Buy$0.0000.00% ROIENOVEnovis5/22/2026Reiterated Rating$24.60$39.00Buy$0.0000.00% ROIGKOSGlaukos5/21/2026Boost Price Target$143.82$162.00Buy$0.0000.00% ROITCMDTactile Systems Technology5/21/2026Reiterated Rating$24.84$40.00Buy$0.0000.00% ROIXTNTXtant Medical5/13/2026Reiterated Rating$0.47$1.00Buy$0.0000.00% ROIHUMAHumacyte5/13/2026Lower Price Target$1.14$2.00Buy$0.0000.00% ROIORGOOrganogenesis5/8/2026Downgrade$2.52Neutral$0.0000.00% ROI Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. CARLCarlsmed5/6/2026Reiterated Rating$8.92$23.00Buy$0.0000.00% ROISOLVSolventum5/6/2026Reiterated Rating$69.09$89.00Buy$0.0000.00% ROIALCAlcon5/6/2026Lower Price Target$65.42$82.00Buy$0.0000.00% ROITCMDTactile Systems Technology5/5/2026Boost Price Target$22.43$40.00Buy$0.0000.00% ROIKIDSOrthoPediatrics5/1/2026Reiterated Rating$15.06$24.00Buy$0.0000.00% ROISYKStryker5/1/2026Lower Price Target$314.64$379.00Buy$0.0000.00% ROIGKOSGlaukos4/30/2026Boost Price Target$116.94$141.00Buy$0.0000.00% ROIGEHCGE HealthCare Technologies4/29/2026Lower Price Target$59.53$80.00Buy$0.0000.00% ROIHUMAHumacyte4/28/2026Reiterated Rating$0.77$3.00Buy$0.0000.00% ROIISRGIntuitive Surgical4/22/2026Reiterated Rating$451.29$574.00Buy$0.0000.00% ROIGEHCGE HealthCare Technologies4/21/2026Reiterated Rating$74.15$85.00Buy$0.0000.00% ROISYKStryker4/14/2026Reiterated Rating$347.28$397.00Buy$0.0000.00% ROIISRGIntuitive Surgical4/10/2026Reiterated Rating$454.94$616.00Buy$0.0000.00% ROIXTNTXtant Medical3/31/2026Lower Price Target$0.57$1.00Buy$0.0000.00% ROIHUMAHumacyte3/27/2026Lower Price Target$0.72$3.00Buy$0.0000.00% ROIORGOOrganogenesis3/26/2026Reiterated Rating$2.44$8.00Buy$0.0000.00% ROIMDAISpectral AI3/25/2026Reiterated Rating$1.65$3.00Buy$0.0000.00% ROIALCAlcon3/23/2026Reiterated Rating$73.59$92.00Buy$0.0000.00% ROIZBHZimmer Biomet3/23/2026Reiterated Rating$88.04Neutral$0.0000.00% ROIGEHCGE HealthCare Technologies3/19/2026Reiterated Rating$70.25$91.00Buy$0.0000.00% ROILNSRLENSAR3/17/2026Upgrade$6.89$10.00Buy$0.0000.00% ROISIShoulder Innovations3/11/2026Boost Price Target$13.09$24.00Buy$0.0000.00% ROIKIDSOrthoPediatrics2/27/2026Boost Price Target$17.79$24.00Buy$0.0000.00% ROIORGOOrganogenesis2/27/2026Lower Price Target$3.70$8.00Buy$0.0000.00% ROISOLVSolventum2/27/2026Reiterated Rating$77.25$100.00Buy$0.0000.00% ROIENOVEnovis2/26/2026Boost Price Target$25.13$43.00Buy$0.0000.00% ROIALCAlcon2/25/2026Boost Price Target$87.02$92.00Buy$0.0000.00% ROITCMDTactile Systems Technology2/18/2026Boost Price Target$28.05$38.00Buy$0.0000.00% ROIGKOSGlaukos2/18/2026Reiterated Rating$107.08$131.00Buy$0.0000.00% ROIMDAISpectral AI2/10/2026Reiterated Rating$1.60$3.00Buy$0.0000.00% ROI9 days. (Ad)SpaceX is set to price on June 12 in what could be the largest IPO in history at a $1.75 trillion valuation. Before that happens, analyst Dylan Jovine says there's one small, publicly traded company that Musk's entire empire depends on - and it's still dirt cheap. Once the S-1 hits and every fund and financial journalist starts digging, this window closes. Jovine is releasing the name and ticker today.See the ticker tied to SpaceX before the June 12 window closesZBHZimmer Biomet2/10/2026Reiterated Rating$92.70$112.00Buy$0.0000.00% ROIHUMAHumacyte2/9/2026Reiterated Rating$1.22$6.00Buy$0.0000.00% ROIGEHCGE HealthCare Technologies2/4/2026Boost Price Target$83.09$91.00Buy$0.0000.00% ROISYKStryker1/30/2026Boost Price Target$354.39$412.00Buy$0.0000.00% ROIGKOSGlaukos1/28/2026Boost Price Target$126.17$131.00Buy$0.0000.00% ROIISRGIntuitive Surgical1/23/2026Reiterated Rating$525.81$616.00Buy$0.0000.00% ROIPENPenumbra1/15/2026Downgrade$350.53$349.00Neutral$0.0000.00% ROIZBHZimmer Biomet1/8/2026Reiterated Rating$92.82$112.00Buy$0.0000.00% ROIISRGIntuitive Surgical1/7/2026Reiterated Rating$592.85$616.00Buy$0.0000.00% ROIENOVEnovis1/6/2026Initiated Coverage$26.98$41.00Buy$0.0000.00% ROIENOVEnovis1/6/2026Initiated Coverage$27.73$41.00Buy$0.0000.00% ROIGKOSGlaukos1/2/2026Reiterated Rating$112.80$116.00Buy$0.0000.00% ROIORGOOrganogenesis12/26/2025Reiterated Rating$5.91$9.00Buy$0.0000.00% ROICARLCarlsmed12/15/2025Reiterated Rating$12.95$24.00Buy$0.0000.00% ROIORGOOrganogenesis12/15/2025Reiterated Rating$4.83$9.00Buy$0.0000.00% ROIRBOTVicarious Surgical12/12/2025Reiterated Rating$2.59Neutral$0.0000.00% ROISOLVSolventum12/2/2025Upgrade$85.57$100.00Buy$0.0000.00% ROISOLVSolventum12/2/2025Upgrade$85.57$100.00Buy$0.0000.00% ROIALCAlcon11/24/2025Reiterated Rating$76.57$91.00Buy$0.0000.00% ROIHUMAHumacyte11/21/2025Reiterated Rating$1.12$6.00Buy$0.0000.00% ROIGEHCGE HealthCare Technologies11/21/2025Reiterated Rating$74.75$87.00Buy$0.0000.00% ROIRCELAvita Medical11/20/2025Upgrade$3.95Neutral$0.0000.00% ROIORGOOrganogenesis11/20/2025Boost Price Target$5.13$9.00Buy$0.0000.00% ROISYKStryker11/14/2025Reiterated Rating$372.93$410.00Buy$0.0000.00% ROIMDAISpectral AI11/12/2025Lower Price Target$1.72$3.00Buy$0.0000.00% ROIXTNTXtant Medical11/11/2025Lower Price Target$0.81$1.50Buy$0.0000.00% ROITMCITreace Medical Concepts11/7/2025Reiterated Rating$6.23Neutral$0.0000.00% ROICARLCarlsmed11/7/2025Boost Price Target$11.89$24.00Buy$0.0000.00% ROIZBHZimmer Biomet11/5/2025Lower Price Target$86.90$112.00Buy$0.0000.00% ROISYKStryker10/31/2025Boost Price Target$369.31$410.00Buy$0.0000.00% ROIGKOSGlaukos10/30/2025Boost Price Target$77.27$116.00Buy$0.0000.00% ROIGEHCGE HealthCare Technologies10/29/2025Set Price Target$77.38$87.00$0.0000.00% ROIKIDSOrthoPediatrics10/29/2025Reiterated Rating$16.91$23.00Buy$0.0000.00% ROIPENPenumbra10/27/2025Reiterated Rating$253.61$320.00Buy$0.0000.00% ROIISRGIntuitive Surgical10/22/2025Boost Price Target$462.74$589.00Buy$0.0000.00% ROIHOLXHologic10/21/2025Reiterated Rating$74.23Neutral$0.0000.00% ROIGKOSGlaukos10/20/2025Reiterated Rating$87.49$104.00Buy$0.0000.00% ROISYKStryker10/13/2025Boost Price Target$364.77$408.00Buy$0.0000.00% ROIGEHCGE HealthCare Technologies10/13/2025Boost Price Target$71.01$89.00Buy$0.0000.00% ROIHUMAHumacyte10/13/2025Lower Price Target$1.56$6.00Buy$0.0000.00% ROIISRGIntuitive Surgical10/13/2025Lower Price Target$429.59$529.00Buy$0.0000.00% ROIZBHZimmer Biomet10/13/2025Boost Price Target$94.79$122.00Buy$0.0000.00% ROIALCAlcon10/13/2025Lower Price Target$71.99$91.00Buy$0.0000.00% ROIGKOSGlaukos10/13/2025Lower Price Target$82.55$104.00Buy$0.0000.00% ROIIRTCiRhythm Technologies10/13/2025Boost Price Target$176.20$195.00Buy$0.0000.00% ROIKIDSOrthoPediatrics10/10/2025Lower Price Target$17.95$23.00Buy$0.0000.00% ROIISRGIntuitive Surgical10/1/2025Reiterated Rating$447.23$571.00Buy$0.0000.00% ROIORGOOrganogenesis9/26/2025Reiterated Rating$4.68$7.00Buy$0.0000.00% ROIVCELVericel9/17/2025Downgrade$33.23Neutral$0.0000.00% ROIPRCTPROCEPT BioRobotics9/16/2025Reiterated Rating$38.00Neutral$0.0000.00% ROITrump's gold order: the announcement they won't put on the front page (Ad)On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no debate, no vote, one executive order. Gold tripled within three years and climbed 20x over the following decade. Trump holds that same executive authority today, and his advisors are openly saying a reversal is on the table. There are two ways this plays out - both move gold in the same direction. A free briefing breaks down exactly what Nixon did, why Trump is positioned to act, and how to move your 401k into gold before any announcement - tax free.Request the free guide in 30 seconds and get positioned nowGKOSGlaukos9/10/2025Reiterated Rating$90.86$118.00Buy$0.0000.00% ROISIShoulder Innovations9/9/2025Reiterated Rating$15.18$23.00Buy$0.0000.00% ROIKIDSOrthoPediatrics8/6/2025Lower Price Target$17.66$39.00Buy$0.0000.00% ROIISRGIntuitive Surgical7/23/2025Boost Price Target$511.00$571.00Buy$0.0000.00% ROIISRGIntuitive Surgical7/14/2025Set Price Target$518.35$566.00Buy$0.0000.00% ROIALCAlcon7/14/2025Set Price Target$87.45$100.00Buy$0.0000.00% ROIRXSTRxSight7/9/2025Reiterated Rating$12.79Neutral$0.0000.00% ROIGMEDGlobus Medical5/27/2025Reiterated Rating$59.00Neutral$00.0000.00% ROISYKStryker4/14/2025Set Price Target$346.69$403.00Buy$000.0000.00% ROIISRGIntuitive Surgical4/14/2025Set Price Target$481.34$560.00Buy$000.0000.00% ROIGEHCGE HealthCare Technologies4/14/2025Set Price Target$61.48$95.00Buy$00.0000.00% ROIISRGIntuitive Surgical10/18/2024Set Price Target$521.89$535.00$000.0000.00% ROIHUMAHumacyte10/18/2024Reiterated Rating$5.24$10.00Buy$0.0000.00% ROI Stock Forecasts and Research Tools Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Top Stock Recommendations by BrokerageWall Street ZenUBS GroupCitigroupBarclaysWells Fargo & CompanyMorgan StanleyRoyal Bank Of CanadaJPMorgan Chase & Co.Jefferies Financial GroupThe Goldman Sachs GroupTD CowenTruist FinancialPiper SandlerStifel NicolausRaymond James Financial Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.